Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 6/20 | 0.49 |
| ▸ | CASP3 | P42574 | 5/20 | 0.49 |
| ▸ | CASP8 | Q14790 | 4/20 | 0.49 |
| ▸ | ACE | P12821 | 3/20 | 0.45 |
| ▸ | MME | P08473 | 2/20 | 0.45 |
| ▸ | KLK7 | P49862 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL647366 | 1.00 | CASP1 (0.49) | CASP1CASP3CASP8ACEMME | |
| SCHEMBL1409861 | 1.00 | CASP1 (0.49) | CASP1CASP3CASP8ACEMME | |
| SCHEMBL644997 | 0.90 | CASP1 (0.60) | CASP1CASP3CASP8ACEMME | |
| SCHEMBL1414605 | 0.90 | CASP1 (0.60) | CASP1CASP3CASP8ACEMME | |
| SCHEMBL1409707 | 0.90 | CASP1 (0.60) | CASP1CASP3CASP8ACEMME | |
| SCHEMBL644933 | 0.89 | CASP1 (0.52) | CASP1CASP3CASP8ACEMME | |
| SCHEMBL644714 | 0.89 | CASP1 (0.52) | CASP1CASP3CASP8ACEMME | |
| SCHEMBL1414638 | 0.89 | CASP1 (0.52) | CASP1CASP3CASP8ACEMME | |
| SCHEMBL1410174 | 0.89 | CASP1 (0.52) | CASP1CASP3CASP8ACEMME | |
| SCHEMBL12450751 | 0.89 | CASP1 (0.52) | CASP1CASP3CASP8ACEMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2083014-A2 | Inhibitors of interleukin-1ß converting enzyme | Vertex Pharmceuticals Incorporated (US) | 2009-07-29 | — | — | EP | disclosed |
| US-6258948-B1 | AN N-ACYLAMINO COMPOUND; ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES | VERTEX PHARMACEUTICALS, INCORPORATED | 2001-07-10 | — | — | US | disclosed |